Kelvin Teo, MBBS, PhD, senior consultant, Advanced Eye Clinic & Surgery, adjunct associate professor, Duke NUS Eye ACP, Singapore, presents real-world data showing that a single 8-mg dose…
Andrew Chang, MBBS, PhD, consultant ophthalmologist and head of Ophthalmology, Sydney Eye Hospital, Australia, shares real-world experience using 8-mg intravitreal aflibercept for neovascular age-related macular degeneration and reports…
In this second installment of Intel’s Jam Session, a panel of experts discuss the current trends, burgeoning innovations, and future trajectory of digital solutions for clinical practice and…
Jonathan Piccini, MD, MHS, Associate Professor of Medicine at Duke University and Duke Clinical Research Institute discusses goals for his forthcoming CHANGE AFib clinical trial. Dr. Piccini emphasizes…
